| 11361/13381 | US=61 / Câncer Melnikova VO, Bar-Eli M. Biological resistance: characteristics of the metastatic phenotype. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 181-200. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. MELANOMA; METASTASE; ANGIOGENESE; REGULACAO TRANSCRICIONAL; AP-2; CREB |
| 11362/13381 | US=61 / Câncer Morin PJ. Biological resistance: the microenvironment and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 201-10. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. MICROAMBIENTE; MATRIZ EXTRACELULAR; CITOCINAS; FACTORES DE CRESCIMENTO; RESISTENCIA AS DROGAS; APOPTOSE; ANOIKIS |
| 11363/13381 | US=61 / Câncer Findlay VJ, Townsed DM, Tew KD. Biochemical resistance: glutathione S-transferases in drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 213-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. GLUTATIONA; GLUTATIONA-S-TRANSFERASE; RESISTENCIA AS DROGAS; CANCER; MAPK; CAMINHO |
| 11364/13381 | US=61 / Câncer Notta F, Koropatnick DJ. Biochemical resistance: metallothioneins in drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 223-39. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. METALOTIONEINAS; GLUTATIONA; CISPLATINA; VARREDORES DE RADICAIS LIVRES; SULFIDRILOS PROTEINA |
| 11365/13381 | US=61 / Câncer Monti E. Biochemical resistance: molecular determinants of intrinsic multidrug resistance in cancer cells and tumors. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 241-60. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 11366/13381 | US=61 / Câncer Bates SE, Deeken J, Fan C, Robey RW. Biochemical resistance: new and revised concepts in multidrug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 261-82. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. MULTIRRESISTENCIA; SNPS; GP170; SETAMIBI; MULTIRRESISTENCIA; DERIVAM DE CELULAS |
| 11367/13381 | US=61 / Câncer Siddik ZH. Biochemical resistance: cisplatin resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 283-307. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CISPLATINA; RESISTENCIA; MECANISMO MOLECULAR; ADUTOS DE DNA; RECONHECIMENTO DE DANOS; DNA DE TOLERANCIA AO DANO; CICLO CELULAR; APOPTOSE |
| 11368/13381 | US=61 / Câncer Safaei R, Howell SB. Biochemical resistance: regulation of the cellular pharmacology and cytotoxicity of cisplatin by copper transporters. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 309-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. CISPLATINA; COBRE; COBRE TRANSPORTADORES METALICOS COMPLEXOS METALLOTRANS PORTEIROS |
| 11369/13381 | US=61 / Câncer Greenberger LM, Sampath D. Biochemical resistance: resistance to taxanes. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 329-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. TAXANOS; RESISTENCIA; MICROTUBULOS; TUBULIN; TRANSPORTADORES; P-GLICOPROTEINA; APOPTOSE; TRANSDUCAO DE SINAL |
| 11370/13381 | US=61 / Câncer Teodoridis JM, Brown R. Biochemical resistance: CpG island methylation and drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 359-75. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 11371/13381 | US=61 / Câncer Hazlehurst LA, Dalton WS. Biochemical resistance: de novo and acquired resistance to antitumor alkylating agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 377-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. AGENTES ALQUILANTES ANTITUMORAIS; DE NOVO A RESISTENCIA; RESISTENCIA ADQUIRIDA; GLUTATIONA; GLUTATIONA-S-TRANSFERASE; FANCONI ANEMIA/BRCA1 CAMINHO |
| 11372/13381 | US=61 / Câncer Sledge Junior GW, Miller KD, Schneider B, Sweeney CJ. Biochemical resistance: resistance to to antiangiogenic agents. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 391-410. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIANGIOGENESIS; FACTORES DE CRESCIMENTO ENDOTELIAIS VASCULARES; RECEPTOR DO FATOR ENDOTELIAL VASCULAR; HIPOXIA; INIBIDORES DA TIROSINA QUINASE |
| 11373/13381 | US=61 / Câncer osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO |
| 11374/13381 | US=61 / Câncer Gandhi V, Sanchez-Vega B. The role of hormones, growth factors, and oncogenes: mechanisms of glucocorticoid actions and resistance in multiple myeloma. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 435-58. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. GLICOCORTICOIDES; RESISTENCIA; PROTEINA RECEPTORA; APOPTOSE; MIELOMA; ISOFORMAS; POSTAR MODIFICACAO DE TRANSLACAO |
| 11375/13381 | US=61 / Câncer Mayer IA, Arteaga CL. The role of hormones, growth factors, and oncogenes: herceptin resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 459-67. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. HERCEPTIN; RECEPTOR DE ESTROGENO; RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL; HER-2; ERB2 |
| 11376/13381 | US=61 / Câncer Pinkas J, Teicher BA. The role of hormones, growth factors, and oncogenes: role of TGF-b in tumor progression and metastasis. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 469-89. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. FATOR DE CRESCIMENTO TRANSFORMANTE-B; RECEPTOR DO FATOR DE CRESCIMENTO TRANSFORMANTE-B; SMAD; OSTEOCLASTOS; FIBROSE |
| 11377/13381 | US=61 / Câncer DeLeo AB. The role of hormones, growth factors, and oncogenes: p53-based immunotherapy of cancer. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 491-505. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. |
| 11378/13381 | US=61 / Câncer Dent P, Yacoub A, Hagan MP, Grant S. The role of hormones, growth factors, and oncogenes: response and resistance to ionizing radiation. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 507-29. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. RADIACAO; SINALIZACAO; QUINASE; FOSFATASE; OXIGENIO / NITROGENIO REATIVO; ESPECIES; RECEPTOR |
| 11379/13381 | US=61 / Câncer Yen MJ, Shih LM, Velculescu VE, Wang TL. The role of hormones, growth factors, and oncogenes: amplification in DNA copy numbers as a mechanism of acquired drug resistance. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 531-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. AMPLIFICACAO; RESISTENCIA AS DROGAS; INSTABILIDADE CROMOSSOMICA; HIBRIDACAO IN SITU FLUORESCENTE; HIBRIDIZACAO GENOMICA COMPARATIVA; CARIOTIPO DIGITAIS |
| 11380/13381 | US=61 / Câncer Sovak MA, Spriggs DR. Clinical aspects of resistance: cancer chemotherapy. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 541-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. RESISTENCIA AS DROGAS CLINICA; BIOMARCADORES; CRITERIOS DE RESPOSTA; QUIMIOTERAPIA COMBINADA; MARCADORES SUBSTITUTOS |